Use of contemporary cardiometabolic therapies in cardiac amyloidosis treated with tafamidis: A real-world propensity-matched analysis

Archives of Cardiovascular Diseases · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles